The Manufacturers Life Insurance Company Sells 2,097 Shares of Trupanion, Inc. (NASDAQ:TRUP)

The Manufacturers Life Insurance Company lowered its holdings in shares of Trupanion, Inc. (NASDAQ:TRUPFree Report) by 11.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,890 shares of the financial services provider’s stock after selling 2,097 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Trupanion were worth $467,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also bought and sold shares of the company. Headlands Technologies LLC bought a new position in Trupanion during the second quarter valued at $162,000. Oppenheimer Asset Management Inc. purchased a new stake in shares of Trupanion in the second quarter valued at $235,000. Bayesian Capital Management LP purchased a new stake in shares of Trupanion in the first quarter valued at $253,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Trupanion by 47.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,190 shares of the financial services provider’s stock valued at $270,000 after acquiring an additional 2,973 shares during the period. Finally, Capstone Investment Advisors LLC purchased a new stake in shares of Trupanion in the first quarter valued at $269,000.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. William Blair assumed coverage on shares of Trupanion in a research note on Friday, July 19th. They issued an “outperform” rating on the stock. Piper Sandler increased their target price on shares of Trupanion from $38.00 to $45.00 and gave the company a “neutral” rating in a research note on Wednesday, October 2nd. Northland Securities raised their price target on shares of Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a research note on Thursday, September 19th. Bank of America raised their price target on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Finally, Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Four investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $41.83.

View Our Latest Analysis on TRUP

Insider Activity

In other news, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the transaction, the chief executive officer now owns 99,984 shares of the company’s stock, valued at $4,647,256.32. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the transaction, the chief executive officer now owns 99,984 shares of the company’s stock, valued at $4,647,256.32. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Fawwad Qureshi sold 640 shares of Trupanion stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $43.12, for a total transaction of $27,596.80. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,764 shares of company stock worth $405,238. 5.50% of the stock is currently owned by corporate insiders.

Trupanion Trading Up 5.1 %

NASDAQ:TRUP opened at $53.50 on Thursday. Trupanion, Inc. has a one year low of $19.14 and a one year high of $54.08. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63. The firm has a market cap of $2.26 billion, a P/E ratio of -118.89 and a beta of 1.73. The firm has a 50-day simple moving average of $44.19 and a 200-day simple moving average of $33.89.

Trupanion (NASDAQ:TRUPGet Free Report) last posted its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.04. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. The business had revenue of $314.80 million during the quarter, compared to analyst estimates of $309.33 million. During the same quarter in the previous year, the business posted ($0.33) EPS. The company’s quarterly revenue was up 16.3% compared to the same quarter last year. Equities analysts anticipate that Trupanion, Inc. will post -0.34 EPS for the current fiscal year.

About Trupanion

(Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Further Reading

Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUPFree Report).

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.